References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Larssonetal(1998)Differentialregionalantagonismof8-OH-DPAT-induceddecreaseinserotoninsynthesisbytwo5-HT1Areceptorantagonists.Eur.J.Pharmacol.346209PMID:9652362
Arboreliusetal(1999)The5-HT1Areceptorantagonistrobalzotancompletelyreversescitalopram-inducedinhibitionofserotonergiccellfiring.Eur.J.Pharmacol.382133PMID:10528148
Johanssonetal(1997)Thepharmacologicalcharacterizationofanovelselective5-hydroxytryptamine-1Areceptorantagonist,NAD-299.J.Pharamacol.Exp.Ther.283216PMID:
Keywords:NAD299hydrochloride,supplier,AstraZeneca,5-HT1A,serotonin,5-HT,receptor,antagonists,NAD299,5-HT1A,Receptors,5-HT1A,Receptors,TocrisBioscience